Pernessa C. Seele

Last updated

Pernessa C. Seele
Pernessa Seele at USCA (21399731071).jpg
BornOctober 15, 1954 (1954-10-15) (age 68)
Lincolnville, South Carolina, U.S.
Occupation(s)Immunlologist, Activist, CEO

Pernessa C. Seele (born October 15, 1954) is an American immunologist and interfaith public health activist. Seele is the CEO and founder of Balm in Gilead, Inc., a religious-based organization that provides support to people with AIDS and their families, as well as working for prevention of HIV and AIDS. In 1989 she initiated the Harlem Week of Prayer, with 50 churches, synagogues and mosques participating. This became an annual event and organizing force for the religious community to respond to the AIDS crisis.

Contents

Seele incorporated a growing organization as "The Balm in Gilead, Inc." This national movement to address public-health issues through communities of faith" [1] has grown to include more than ten thousand churches, and numerous branches in the United States, Africa and the Caribbean. After 30 years in New York, Seele and the organization are now based in Richmond, Virginia. [2]

Early life and education

Pernessa Seele was born to Luella and Charles Seele in Lincolnville, South Carolina, about 20 miles from Charleston. It was an all-black rural town, where religious revivals were part of the community fabric and a way to mobilize civic action. [3]

Seele studied biology as an undergraduate at Clark College (now Clark Atlanta University) where she earned a B.S. In 1979 she earned a master's degree in immunology at Atlanta University. She went to New York to start a career in science research.

Career

Seele went to New York to work at Rockefeller University in the immunology of malaria. [4] Then she took a job at Sloan Kettering Memorial Hospital in cancer research. Still in her twenties, she moved out of that to do what she called "little jobs". [4]

In the early 1980s, the biological mechanisms of AIDS were still unknown, but the medical community was becoming aware of an epidemic crisis. Seele felt called to use her immunology degree in a different way. Seele developed one of the first AIDS education programs, held at a methadone clinic. She worked at Harlem Hospital as an administrator in the AIDS Initiative Program. Confronted with the needs of patients and their families in the wards, she decided to try to organize the large Harlem religious community in their support. [4]

Harlem religious communities at first associated the disease with downtown gay men.

Religious leaders like Frederick Williams and Preston Washington credit a fiery former immunologist, Pernessa C. Seele, for changing the way they see the disease. As an administrator at Harlem Hospital, Ms. Seele grew weary of watching dozens of patients die alone, without the spiritual support of their congregations. [5]

In 1989 Seele met with leaders of 50 churches, mosques, and Ethiopian Hebrews, to ask them to come together in prayer and education, for the first Harlem Week of Prayer. Religious congregations were encouraged to include education programs on AIDS and its prevention, as well as to create support for patients and their families. Her leadership was supported by major religious leaders in Harlem: Dr. Preston Washington, Dr. Frederick B. Williams, Dr. Wyatt Tee Walker, Dr. Calvin O. Butts, Bishop Norman N. Quick, Dr. James A. Forbes, and numerous others. [4]

By 1991, 100 congregations participated in the annual week of prayer, as the Harlem community came to realize that HIV/AIDS was their disease, too. [6] The Harlem Week of Prayer and mobilization began to receive national attention. Seele was invited to churches and public health groups in other cities to speak about it.

Seele's effort to address public health issues through communities of faith received technical assistance and support from the federal government. She received funding from the Centers for Disease Control and Prevention (CDC) to expand the program to six pilot cities. The CDC recognized the potential of the movement to prevent HIV/AIDS and support patients. Seele incorporated the Balm in Gilead, Inc., to create an organization with non-profit status. [3]

By 2003 the organization reached 10,000 churches, and 70 community organizations had been created to implement its programs in the United States, some African nations, and the Caribbean. Through a cooperative agreement with the CDC, the Balm in Gilead, Inc. operates the Black Church HIV/AIDS National Technical Assistance Center. For years CDC has provided funding and technical assistance to communities of faith to mobilize efforts in education and prevention of HIV/AIDS. [7]

In 2004 Seele and her organization launched the African American Denominational Leadership Health Initiative. It was a partnership between the Balm In Gilead and the women's societies and councils of three Black religious denominations: the African Methodist Episcopal Church (AME), the African Methodist Episcopal Zion Church and the Christian Methodist Episcopal Church. It was designed to build the capacity of these denominations to address cervical cancer, HIV/AIDS and other health issues in Black communities. [2]

Legacy and honors (selected)

Citations

  1. 1 2 Christine Gorman, "Pernessa Seele", Time, April 30, 2006, accessed January 23, 2009
  2. 1 2 3 Denise Rolark Barnes and Gloria Wheatfall, "When it Comes to Churches, Pernessa Seele is the Balm", BlackAids.org, August 9, 2008, accessed January 23, 2009
  3. 1 2 Dorie J. Gilbert and Ednita M. Wright, African American Women and HIV/AIDS, Westport, CT: Greenwood Publishing Company, 2003, p. 155, accessed January 23, 2009
  4. 1 2 3 4 Dorie J. Gilbert and Ednita M. Wright, African American Women and HIV/AIDS, Westport, CT: Greenwood Publishing Company, 2003, p. 154, accessed January 23, 2009
  5. ↑ Andrew Jacobs, "A New Antagonist for AIDS", New York Times, December 1, 1996, accessed January 26, 2009
  6. ↑ Shipp, E.R.; Navarro, Mirey (November 18, 1991). "Reluctantly, Black Churches Confront AIDS". New York Times .
  7. ↑ Dorie J. Gilbert and Ednita M. Wright, African American Women and HIV/AIDS, Westport, CT: Greenwood Publishing Company, 2003, p. 156, accessed January 23, 2009

Related Research Articles

<span class="mw-page-title-main">HIV/AIDS in the United States</span> Epidemic in the United States

The AIDS epidemic, caused by HIV, found its way to the United States between the 1970s and 1980s, but was first noticed after doctors discovered clusters of Kaposi's sarcoma and pneumocystis pneumonia in homosexual men in Los Angeles, New York City, and San Francisco in 1981. Treatment of HIV/AIDS is primarily via the use of multiple antiretroviral drugs, and education programs to help people avoid infection.

<span class="mw-page-title-main">Joint United Nations Programme on HIV/AIDS</span> United Nations organization

The Joint United Nations Programme on HIV and AIDS (UNAIDS) is the main advocate for accelerated, comprehensive and coordinated global action on the HIV/AIDS pandemic.

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir. Gilead is a member of the NASDAQ Biotechnology Index and the S&P 500.

<span class="mw-page-title-main">President's Emergency Plan for AIDS Relief</span> United States governmental initiative

The United States President's Emergency Plan For AIDS Relief (PEPFAR) is a United States governmental initiative to address the global HIV/AIDS epidemic and help save the lives of those suffering from the disease. Launched by U.S. President George W. Bush in 2003, as of May 2020, PEPFAR has provided about $90 billion in cumulative funding for HIV/AIDS treatment, prevention, and research since its inception, making it the largest global health program focused on a single disease in history until the COVID-19 pandemic. PEPFAR is implemented by a combination of U.S. government agencies in over 50 countries and overseen by the Global AIDS Coordinator at the United States Department of State. As of 2021, PEPFAR has saved over 20 million lives, primarily in Sub-Saharan Africa.

<span class="mw-page-title-main">Emtricitabine/tenofovir</span> Drug combination for HIV/AIDS prophylaxis and treatment

Emtricitabine/tenofovir, sold under the brand name Truvada among others, is a fixed-dose combination antiretroviral medication used to treat and prevent HIV/AIDS. It contains the antiretroviral medications emtricitabine and tenofovir disoproxil. For treatment, it must be used in combination with other antiretroviral medications. For prevention before exposure, in those who are at high risk, it is recommended along with safer sex practices. It does not cure HIV/AIDS. Emtricitabine/tenofovir is taken by mouth.

Calvin Otis Butts III was an American academic administrator and a senior pastor of the Abyssinian Baptist Church, which historically was the largest black church in New York City. He led the Abyssinian Development Corporation, which focuses on Harlem, and was president of the State University of New York College at Old Westbury.

<span class="mw-page-title-main">Pre-exposure prophylaxis</span> HIV prevention strategy using preventative medication for HIV-negative individuals

Pre-exposure prophylaxis (PrEP) is the use of medications to prevent the spread of disease in people who have not yet been exposed to a disease-causing agent, usually a virus. The term typically refers to the use of antiviral drugs as a strategy for the prevention of HIV/AIDS. PrEP is one of a number of HIV prevention strategies for people who are HIV negative but who have a higher risk of acquiring HIV, including sexually active adults at increased risk of contracting HIV, people who engage in intravenous drug use, and serodiscordant sexually active couples.

<span class="mw-page-title-main">James A. Forbes</span>

James Alexander Forbes, Jr. is the Senior Minister Emeritus of the Riverside Church, an interdenominational church on the Upper West Side of Manhattan, New York City. He was the first African American minister to lead this multicultural congregation, and served it for 18 years.

AIDS service organizations are community-based organizations that provide support for people affected by HIV/AIDS. This article focuses on HIV/AIDS service organizations in the United States only.

The HIV/AIDS Bureau is a part of the Health Resources and Services Administration (HRSA), an agency of the United States Department of Health and Human Services. It was established to deal with the growing problem of HIV/AIDS in the United States since the early 1980s.

<span class="mw-page-title-main">Malawi–United States relations</span> Bilateral relations

The United States established diplomatic relations with Malawi in 1964 after Malawi gained independence from the United Kingdom. Malawi's transition from a one-party state to a multi-party democracy significantly strengthened the already cordial U.S. relationship with Malawi. Significant numbers of Malawians study in the United States. The United States has an active Peace Corps program, Centers for Disease Control and Prevention, Department of Health and Human Servicess, and an Agency for International Development (USAID) mission in Malawi. Both countries have a common history and English language, as they were part of the British Empire.

NMAC, formerly known as the National Minority AIDS Council, works for health equity and racial justice to end the HIV epidemic in America. The nonprofit organization, located in Washington, D.C. was founded in 1987. NMAC represents over 3,000 community- and faith-based organizations across the US. The agency advances its mission by providing minority and minority-serving faith- and community-based organizations with capacity building assistance programs, online and classroom-based trainings, printed and electronic resources, grassroots organization and political advocacy. These activities improve the delivery of HIV/AIDS services, helping to mitigate the impact of HIV/AIDS in underserved and marginalized communities.

HIV/AIDS in Eswatini was first reported in 1986 but has since reached epidemic proportions. As of 2016, Eswatini had the highest prevalence of HIV among adults aged 15 to 49 in the world (27.2%).

Frederick Boyd Williams was a religious leader of national importance in the United States. As Canon of the Church of the Intercession in Harlem, New York from 1971 to 2005, he led an influential congregation, the first in the nation to establish a programmatic response to AIDS. A patron of the arts, he provided the first home for the Boys Choir of Harlem. He was a co-founder of the Harlem Congregations for Community Improvement (HCCI), which coordinated 90 congregations to develop 2000 units of housing and retail space. While earning a doctorate from Colgate Rochester Divinity School, he led a congregation that worked for civil rights and social justice, both in the United States and Africa.

The relationship between religion and HIV/AIDS has been an ongoing one, since the advent of the pandemic. Many faith communities have participated in raising awareness about HIV/AIDS, offering free treatment, as well as promoting HIV/AIDS testing and preventative measures. Christian denominations, such as Lutheranism and Methodism, have advocated for the observance of World AIDS Day to educate their congregations about the disease. Some Churches run voluntary blood testing camps and counselling centers to diagnose and help those affected by HIV/AIDS.

<span class="mw-page-title-main">HIV-affected community</span> Medical condition

The affected community is composed of people who are living with HIV and AIDS, plus individuals whose lives are directly influenced by HIV infection. This originally was defined as young to middle aged adults who associate with being gay or bisexual men, and or injection drug users. HIV-affected community is a community that is affected directly or indirectly affected by HIV. These communities are usually influenced by HIV and undertake risky behaviours that lead to a higher chance of HIV infection. To date HIV infection is still one of the leading cause of deaths around the world with an estimate of 36.8 million people diagnosed with HIV by the end of 2017, but there can particular communities that are more vulnerable to HIV infection, these communities include certain races, gender, minorities, and disadvantaged communities. One of the most common communities at risk is the gay community as it is commonly transmitted through unsafe sex. The main factor that contributes to HIV infection within the gay/bisexual community is that gay men do not use protection when performing anal sex or other sexual activities which can lead to a higher risk of HIV infections. Another community will be people diagnosed with mental health issues, such as depression is one of the most common related mental illnesses associated with HIV infection. HIV testing is an essential role in reducing HIV infection within communities as it can lead to prevention and treatment of HIV infections but also helps with early diagnosis of HIV. Educating young people in a community with the knowledge of HIV prevention will be able to help decrease the prevalence within the community. As education is an important source for development in many areas. Research has shown that people more at risk for HIV are part of disenfranchised and inner city populations as drug use and sexually transmitted diseases(STDs) are more prevalent. People with mental illnesses that inhibit making decisions or overlook sexual tendencies are especially at risk for contracting HIV.

Discrimination against people with HIV/AIDS or serophobia is the prejudice, fear, rejection, and stigmatization of people with HIV/AIDS. Marginalized, at-risk groups such as members of the LGBTQ+ community, intravenous drug users, and sex workers are most vulnerable to facing HIV/AIDS discrimination. The consequences of societal stigma against PLHIV are quite severe, as HIV/AIDS discrimination actively hinders access to HIV/AIDS screening and care around the world. Moreover, these negative stigmas become used against members of the LGBTQ+ community in the form of stereotypes held by physicians.

HIV prevention refers to practices that aim to prevent the spread of the human immunodeficiency virus (HIV). HIV prevention practices may be undertaken by individuals to protect their own health and the health of those in their community, or may be instituted by governments and community-based organizations as public health policies.

<span class="mw-page-title-main">HIV/AIDS activism</span> Social movement advocating for a societal response to HIV/AIDS

Social and political activism to raise awareness about HIV/AIDS, as well as to raise funds for effective treatment and care of people with AIDS (PWAs), has taken place in multiple nations across the world since the 1980s. As a disease that began in marginalized populations, efforts to mobilize funding, treatment, and fight discrimination have largely been dependent on the work of grassroots organizers directly confronting public health organizations as well as politicians, drug companies, and other institutions.

<span class="mw-page-title-main">Oni Blackstock</span> American physician and academic

Oni Blackstock is a primary care and HIV physician, researcher, and founder of Health Justice, a racial and health equity consulting practice. She previously served as assistant commissioner for the Bureau of HIV for the New York City Department of Health, where she led the city's response to the HIV epidemic. Her research considers the experiences of women and people of color in healthcare. During the COVID-19 pandemic Blackstock shared advice on how people in New York City could maintain sexual health and slow the spread of COVID-19 as well as guidance for people with HIV and HIV care providers about the intersection of HIV and COVID-19.

References

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.